immunology 2017 washington monumentThe Annual AAI Immunology Meeting focuses on innovative immunology research and science from investigators around the globe. Join colleagues from 40+ countries as they share new immunology research and expertise during this exciting five-day conference. Visit booth 838 to learn about Taconic’s model offerings and receive a giveaway from Taconic.

Meet The Taconic Team at Immunology 2017:

Kevin Riley, Kerry Robinson, Sarala Sarah, Alexander Maue, PhD, Azusa Tanaka, PhD, and Phillip Dubé, PhD

Exhibitor Workshops

Taconic Biosciences is excited to offer two exhibitor workshops!

Enhanced Human Hemato-/Myelopoiesis in Humanized hGM-CSF/hIL3-NOG Mice Compared with Humanized NOG Mice

Monday, May 15 at 11:15 a.m. to 12 p.m. ET

Exhibitor Workshop Room 1

Presenters:

  • Azusa Tanaka, PhD, Product Manager of Precision Research Models, Taconic Biosciences
  • Gerold Feuer, PhD, Founder/Chief Scientific Officer, HuMurine Technologies

Abstract:

The humanized immune system CIEA NOG mouse® (NOG) has become a powerful tool to evaluate a wide range of preclinical applications, including the safety and efficacy of immune checkpoint inhibitors—agents that stimulate human hematopoiesis and gene therapies against HIV-1 infection. Taconic, the sole provider of the NOG portfolio in the European Union and the United States, will present data supporting the consistency, reliability, and chimeric ratios for the production of over 1,500 humanized NOG (huNOG) and over 800 humanized hGM-CSF/hIL-3 NOG (huNOG-EXL). Dr. Gerold Feuer, Ph.D , founder and Chief Scientific Officer of HuMurine Technologies will present its recently developed and validated humanized mouse platform: humanization of Taconic Bioscience’s hGM-CSF/hIL-3 NOG mouse (Hu-3GM™). The humanization platform is based on the Hu-M™ mouse, HuMurine’s commercially successful humanized immune system NOG mouse that supports consistent and robust levels of human hematopoiesis. Expect to learn about the comparatively analyzed kinetics and robustness of human lympho- and myelopoiesis of both the Hu-3GM™ and Hu-M™ mice and advantages and disadvantages of working with both models. 

Harnessing the Microbiome in Mouse Research

Monday, May 15 at 1:45 to 2:30 p.m. ET

Exhibitor Workshop Room 1

Presenters:

  • Philip Dubé, PhD, Field Application Scientist, Taconic Biosciences
  • Alexander Maue, PhD, Director Microbiome Products and Services, Taconic Biosciences

Abstract:

The microbiome is emerging as a critical factor in the development and function of the immune system. Dysbiosis, an imbalance in the community structure of the microbiome, is associated with the development and progression of numerous diseases, and therapeutic strategies targeting the microbiome are gaining traction. This revolution has been driven by basic research in mice, which has furthered our understanding of how the microbiome influences homeostasis and disease. This seminar will provide an overview of the strategies and solutions to study the microbiome and to control for its effects and will emphasize the latest resources available for researchers.

Abstract Presentation

Taconic Biosciences' Dr. Azusa Tanaka will also be presenting an abstract:

Engraftment of Human Immune System and Human Tumor Xenograft in Murine Models: Applications in Oncology Drug Discover P758

Sunday, May 14 at 2:30 p.m. to 3:45 p.m. ET

Presenter:

  • Azusa Tanaka, PhD, Product Manager of Precision Research Models, Taconic Biosciences

Meet With a Taconic Expert!

Talk to a Taconic Scientific Expert at Immunology 2017

© 2018 Taconic Biosciences, Inc. All rights reserved.

© 2018 Taconic Biosciences, Inc. All rights reserved.